No images? Click here

 
 
 
 

19 July 2024

Cover visual of the new publication
 
 

Surveillance and control of Anopheles stephensi: country experiences 

Anopheles stephensi is an invasive mosquito species that has been detected, to date, in 8 African countries. While this species presents a new challenge for malaria control on the continent, its surveillance and management have been ongoing in Asia for many years. A new publication from the Global Malaria Programme summarizes key lessons from 3 countries: India, the Islamic Republic of Iran and Sri Lanka.

New publication | WHO initiative to stop the spread of Anopheles stephensi in Africa | Video: the spread of Anopheles stephensi in Africa

 
 

Côte d’Ivoire and South Sudan introduce the R21 malaria vaccine

 

Côte d’Ivoire and South Sudan launched national roll-outs of the R21 vaccine this week, with support from Gavi, UNICEF and WHO – the latest milestone in efforts to improve access to a vital malaria prevention tool for children at risk of the disease. The two WHO-recommended malaria vaccines (RTS,S and R21) are safe, effective and expected to have high public health impact. Integrating the vaccines with other WHO-recommended prevention measures will ensure the best protection for children. 

Joint WHO-Gavi-UNICEF news release: South Sudan launches R21 malaria vaccine rollout to protect children

 
 

Recent meeting reports 

  • Twentieth meeting of the WHO Vector Control Advisory Group (VCAG): This report details proceedings and outcomes of the latest VCAG meeting, held on 25-28 March 2024, including advice provided to applicants working on interventions in the following areas: spatial repellents, topical repellents, and sterilization of male mosquitoes.
     
  • Report from the Malaria Policy Advisory Group (MPAG): At the latest MPAG meeting, held in Yaoundé, Cameroon on 4,5 and 7 March 2024, MPAG members reviewed updates and progress on the introduction and scale-up of the malaria vaccine; the “High Burden to High Impact” approach; subnational tailoring and guiding principles for prioritization; biological threats to vector control; antimalarial drug resistance in Africa; tafenoquine, primaquine and near-patient glucose-6-phosphate dehydrogenase (G6PD) diagnostic tests; and malaria elimination, including zoonotic malaria.
     
  • Report of the third, fourth and fifth meetings of the Technical Advisory Group on Malaria Elimination and Certification (TAG-MEC): This report describes the proceedings and outcomes of three meetings held by the TAG-MEC in February, May and November 2023. Topics covered include the malaria-free certifications of Belize and Cabo Verde, global guidance on the prevention of re-establishment of malaria, proposed changes to the 2017 Framework for malaria elimination, the situation of malaria elimination at the global level, and the issue of P. knowlesi. 
 

Translations

The following publication is now available in French:

  • Déploiement du traitement préventif intermittent du paludisme pendant la grossesse à base de sulfadoxine-pyriméthamine dans les communautés: guide du terrain. Ce guide décrit les étapes essentielles et donne des orientations aux pays pour l’adoption et le déploiement du c-TPIg de manière à l’intégrer dans le système de santé existant. 
 
 
 

Subscribe

 

Toolkit app

Guidelines

FacebookTwitterYouTubeWebsite
 
 
 
  Tweet 
  Forward 
Global Malaria Programme
World Health Organization
Avenue Appia 20
1211, Geneva 27, Switzerland

To keep receiving emails from us, please add @who.int and @campaign.who.int to your address book.

You are receiving this message because of your working relationship with WHO/GMP.
Unsubscribe